Clinical trials · Portland, OR
HER2-positive Breast Cancer clinical trials in Portland
We’re tracking 6 recruiting her2-positive breast cancer studies with a site in or near Portland — including Phase 1, Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Portland
- NCT07007559RecruitingPhase 2
Evorpacept with trastuzumab and chemo for HER2-positive breast cancer
This study tests an experimental drug called evorpacept when given with trastuzumab and chemotherapy for people with HER2-positive breast cancer that has spread. The goal is to see if this combination can shrink tumors or slow down the cancer.
Portland, OregonAges 18 years+ - NCT06253871RecruitingPhase 1
Study of IAM1363 for HER2 Cancers
This trial tests a new oral drug called IAM1363 for people with HER2-altered cancers that have stopped responding to previous treatments. The goal is to see if the drug is safe and how well it works against these cancers.
Portland, OregonAges 18 years+ - NCT01042379RecruitingPhase 2
Adaptive drug trial for newly diagnosed breast cancer
This study tests personalized, changing treatment plans (given before surgery) to find better options for your specific breast tumor. You may be asked for extra breast-tissue testing to help match you with the most suitable study drug(s).
Portland, OregonAges 18 years+ - NCT04585750RecruitingPhase 1/Phase 2
Study drug for TP53 Y220C-mutated advanced cancers
This early-phase study tests PC14586 (rezatapopt) in people with advanced or metastatic solid cancers that carry a specific TP53 mutation called Y220C. It mainly looks at safety and how well the treatment may work, sometimes combined with pembrolizumab.
Portland, OregonAges 12 years+ - NCT05256225RecruitingPhase 3
Adding Herceptin medicines to chemo for HER2-positive endometrial cancer
This Phase 3 trial tests whether adding Herceptin Hylecta or Phesgo to standard chemotherapy works better than chemotherapy alone for HER2-positive serous endometrial cancer or carcinosarcoma. It may help by improving how well treatment controls or shrinks the cancer.
Portland, OregonAges 18 years+ - NCT07102381RecruitingPhase 2
Zanidatamab plus chemo before surgery for HER2+ breast cancer
This trial tests a new drug called zanidatamab combined with chemotherapy to shrink HER2-positive breast cancer before surgery. It may help improve treatment outcomes for people with stage 2 or 3 breast cancer that has not spread.
Vancouver, WashingtonAges 18 years+
Hear when a new HER2-positive Breast Cancer trial opens near Portland, OR
We’ll email you when one opens near Portland, OR — at most once a week, no account needed, unsubscribe anytime.
HER2-positive Breast Cancer trials in other cities
Where these studies are running near Portland
Institutions with a site for the recruiting her2-positive breast cancer studies listed above.
- Oregon Health and Science University · 4 studies
- Legacy Good Samaritan Hospital and Medical Center
- Legacy Meridian Park Medical Center
- Legacy Salmon Creek Medical Center
- Northwest Cancer Specialists, P.C. (Compass Oncology - Vancouver Cancer Center)
- Providence Cancer Institute Clackamas Clinic
- Providence Health & Services
- Providence Newberg Medical Center
What taking part in a her2-positive breast cancer study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting her2-positive breast cancer studies in Oregon.
Common questions
- Are there her2-positive breast cancer clinical trials near Portland?
- Yes. We're currently tracking 6 recruiting her2-positive breast cancer studies with a site near Portland, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a her2-positive breast cancer study near Portland?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Portland to take part?
- Not necessarily. These studies have a site near Portland, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a her2-positive breast cancer trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New her2-positive breast cancer studies open near Portland regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.